Quadrant Capital Group’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3
| Closed | -$166 | – | 2172 |
|
|
2026
Q1 | $166 | Buy |
+3
| New | +$143 | ﹤0.01% | 2678 |
|
|
2023
Q4 | – | Sell |
-153
| Closed | -$1.95K | – | 2758 |
|
|
2023
Q3 | $1.95K | Sell |
153
-63
| -29% | -$893 | ﹤0.01% | 2399 |
|
|
2023
Q2 | $2.96K | Hold |
216
| – | – | ﹤0.01% | 2327 |
|
|
2023
Q1 | $3.31K | Buy |
216
+63
| +41% | +$963 | ﹤0.01% | 2318 |
|
|
2022
Q4 | $2.05K | Sell |
153
-299
| -66% | -$4.01K | ﹤0.01% | 2409 |
|
|
2022
Q3 | $6K | Buy |
452
+320
| +242% | +$5.53K | ﹤0.01% | 2084 |
|
|
2022
Q2 | $3K | Buy |
132
+88
| +200% | +$1.67K | ﹤0.01% | 2131 |
|
|
2022
Q1 | $1K | Buy |
+44
| New | +$889 | ﹤0.01% | 2354 |
|
|
2021
Q4 | – | Sell |
-62
| Closed | -$1K | – | 2647 |
|
|
2021
Q3 | $1K | Buy |
+62
| New | +$1.49K | ﹤0.01% | 2363 |
|
|
2020
Q3 | – | Sell |
-82
| Closed | -$2K | – | 2268 |
|
|
2020
Q2 | $2K | Hold |
82
| – | – | ﹤0.01% | 1938 |
|
|
2020
Q1 | $2K | Sell |
82
-123
| -60% | -$3.01K | ﹤0.01% | 1882 |
|
|
2019
Q4 | $4K | Buy |
205
+170
| +486% | +$3.95K | ﹤0.01% | 2134 |
|
|
2019
Q3 | $0 | Sell |
35
-41
| -54% | -$1.12K | ﹤0.01% | 2362 |
|
|
2019
Q2 | $2K | Hold |
76
| – | – | ﹤0.01% | 2151 |
|
|
2019
Q1 | $2K | Hold |
76
| – | – | ﹤0.01% | 2077 |
|
|
2018
Q4 | $2K | Hold |
76
| – | – | ﹤0.01% | 1920 |
|
|
2018
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 1892 |
|
|
2018
Q2 | $2K | Hold |
76
| – | – | ﹤0.01% | 1900 |
|
|
2018
Q1 | $2K | Hold |
76
| – | – | ﹤0.01% | 1872 |
|
|
2017
Q4 | $2K | Hold |
76
| – | – | ﹤0.01% | 1815 |
|
|
2017
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 1820 |
|
|
2017
Q2 | $1K | Hold |
76
| – | – | ﹤0.01% | 1740 |
|
|
2017
Q1 | $1K | Hold |
76
| – | – | ﹤0.01% | 1849 |
|
|
2016
Q4 | $2K | Buy |
76
+41
| +117% | +$1.12K | ﹤0.01% | 1524 |
|
|
2016
Q3 | $0 | Buy |
+35
| New | +$792 | ﹤0.01% | 2053 |
|
|
2016
Q2 | – | Sell |
-23
| Closed | – | – | 2046 |
|
|
2016
Q1 | $0 | Buy |
+23
| New | +$659 | ﹤0.01% | 1926 |
|
Other funds holding PAHC
Quadrant Capital Group's PAHC Position: Q2 2026 in Review
Quadrant Capital Group sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 3 shares — an estimated $166 sold.
Quadrant Capital Group first reported a position in PAHC in Q1 2016 and held it in 26 quarters. The position peaked at $6K in Q3 2022. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Quadrant Capital Group reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 3 Phibro Animal Health shares in Q2 2026, an estimated $166.
- Quadrant Capital Group first reported a position in Phibro Animal Health in Q1 2016 and held it in 26 quarters.
- Quadrant Capital Group's Phibro Animal Health position peaked at $6K in Q3 2022.
- 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.